P/E ratio for AquaBounty (AQB)
P/E ratio as of May 2024 (TTM): -0.3737
According to AquaBounty's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.373674. At the end of 2022 the company had a P/E ratio of -0.1632.
P/E ratio history for AquaBounty from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.1632 | -63.62% |
| 2021 | -0.4487 | -67.52% |
| 2020 | -1.38 | 559.65% |
| 2019 | -0.2095 | 33.85% |
| 2018 | -0.1565 | -31.09% |
| 2017 | -0.2271 | -79.9% |
| 2016 | -1.13 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -0.4614 | 23.47% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -2.69 | 620.83% | 🇬🇧 UK |
 Novavax NVAX | -0.6551 | 75.31% | 🇺🇸 USA |
 Novocure
NVCR | -7.63 | 1,941.63% | Jersey |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.